112
S.-Q. Wang et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 106 (2013) 110–117
fluorescence spectra, scan speed was 600 nm minꢁ1 using a quartz
cell of 1 cm optical path length. And the UV–vis absorption spectra
were recorded in a standard 1 cm path length quartz cell in range
250–600 nm with spectral resolution 1 nm. The general equation
used in the determination of relative quantum yields from earlier re-
search was given in Eq. (3) [21].
4-Methyl-2-(5-phenyl-1-(5-phenyl-1,3,4-thiadiazol-2-yl)-4,5-
dihydro-1H-pyrazol-3-yl)phenol (3d). Yellow solid, yield 63.9%; mp
236–238 °C; IR (KBr, cmꢁ1): 3166.4, 3063.1, 3027.2, 2920.1,
1622.3, 1594.3, 1525.2, 1493.6; 1H NMR (300 MHz, CDCl3): d 2.28
(s, 3H, CH3), 3.52 (dd, 1H, J = 6.0, 17.7 Hz, 4-Htrans), 4.12 (dd, 1H,
J = 11.1, 17.7 Hz, 4-Hcis), 5.84 (dd, 1H, J = 6.0, 11.1 Hz, 5-H of pyraz-
oline), 6.99 (d, 2H, J = 8.4 Hz, ArAH), 7.17 (dd, 1H, J = 1.5, 8.4 Hz,
ArAH), 7.30–7.42 (m, 8H, ArAH), 8.05 (dd, 2H, J = 3.0, 6.6 Hz,
ArAH), 9.67 (s, 1H, OH); HRMS: calcd for [M+H]+ C24H20N4OS:
413.1436; found: 413.1461.
UF ¼ ðUFSÞðFAuÞðAsÞðg2uÞ=ðFAsÞðAuÞðgs2
Þ
ð3Þ
where UF and FA are fluorescence quantum yield and integrated
area under the corrected emission spectrum, respectively; A is
2-(1-(5-(4-Methoxyphenyl)-1,3,4-thiadiazol-2-yl)-5-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)-4-methylphenol (3e). Yellow solid, yield
84.7%; mp 236–237 °C; IR (KBr, cmꢁ1): 3206.6, 3068.8, 3031.0,
2931.7, 2910.8, 1606.2, 1572.9, 1493.7, 1483.5; 1H NMR
(300 MHz, CDCl3): 2.29 (s, 3H, CH3), 3.50 (dd, 1H, J = 6.0, 16.8 Hz,
4-Htrans), 3.84 (s, 3H, CH3), 4.10 (dd, 1H, J = 13.2, 16.8 Hz, 4-Hcis),
5.80 (dd, 1H, J = 6.0, 13.2 Hz, 5-H of pyrazoline), 6.93 (d, 2H,
J = 9.0 Hz, ArAH), 7.00 (d, 2H, J = 8.4 Hz, ArAH), 7.17 (d, 1H,
J = 9.0 Hz, ArAH), 7.29–7.42 (m, 5H, ArAH), 7.74 (d, 2H, J = 8.7 Hz,
ArAH), 9.68 (s, 1H, OH); HRMS: calcd for [M+H]+ C25H22N4O2S:
443.1542; found: 443.1522.
2-(1-(5-(4-Chlorophenyl)-1,3,4-thiadiazol-2-yl)-5-phenyl-4,5-
dihydro-1H-pyrazol-3-yl)-4-methylphenol (3f). Yellow solid, yield
55.4%; mp 246–247 °C; IR (KBr, cmꢁ1): 3251.0, 3026.8, 2921.5,
1619.9, 1587.5, 1520.8, 1491.1; 1H NMR (300 MHz, CDCl3): 2.28
(s, 3H, CH3), 3.51 (dd, 1H, J = 5.4, 18.0 Hz, 4-Htrans), 4.12 (dd, 1H,
J = 12.9, 18.0 Hz, 4-Hcis), 5.80 (dd, 1H, J = 5.4, 12.9 Hz, 5-H of pyraz-
oline), 6.98 (d, 2H, J = 8.4 Hz, ArAH), 7.17 (d, 1H, J = 9.3 Hz, ArAH),
7.30–7.41 (m, 7H, ArAH), 7.72 (d, 2H, J = 8.4 Hz, ArAH), 9.63 (s, 1H,
OH); HRMS: calcd for [M+H]+ C24H19ClN4OS: 447.1046; found:
447.1071.
absorbance at the excitation wavelength;
g represent the refractive
index of the solution; and the subscripts u and s refer to the un-
known and the standard, respectively. Furthermore, the energy
yield off fluorescence (EF), which is calculated by Eq. (4), also can
be used instead of the fluorescence quantum yield (UF).
EF ¼ UFðkA=kFÞ
ð4Þ
General procedure for the synthesis of compounds 3a–f
To a stirred solution of substituted chalcone (1) (1.0 mmol) in
ethanol (15 mL) was added 5-aryl-2-hydrazinyl-1,3,4-thiadiazole
(2) (1.2 mmol) and NaOH (3.0 mmol) and the reaction mixture
was refluxed for 3–6 h as shown in Scheme 1. The progress of
the reaction was monitored by TLC. The reaction mixture was al-
lowed to cool to room temperature, and the solvent was evapo-
rated under reduced pressure. The residue was dissolved in
dichloromethane (30 mL), and then washed with water (50 mL)
and brine (20 mL). The organic layer was collected and dried over
MgSO4. After filtration, the solvent was removed under reduced
pressure. The crude product was purified by silica gel column chro-
matography with petroleum dichloromethane/ethyl acetate (15:1;
v/v) as the eluting solvent to give the desired products 3a–3f.
X-ray crystallography
Suitable single crystals of 3b for X-ray structural analysis were
obtained by slow evaporation of a solution of the solid in dichloro-
methane at room temperature for 14 days. The diffraction data
were collected with a Bruker SMART CCD diffractometer using a
The spectroscopic data of compounds 3a–3f
4-Chloro-2-(5-phenyl-1-(5-phenyl-1,3,4-thiadiazol-2-yl)-4,5-
dihydro-1H-pyrazol-3-yl)phenol (3a). Yellow solid, yield 67.4%; mp
228–230 °C; IR (KBr, cmꢁ1): 3192.6, 3063.1, 3026.4, 2921.7,
1614.3, 1587.9, 1522.5, 1483.0; 1H NMR (400 MHz, CDCl3): d 3.48
(dd, 1H, J = 6.6, 17.6 Hz, 4-Htrans), 4.05 (dd, 1H, J = 12.0, 17.6 Hz,
4-Hcis), 5.72 (dd, 1H, J = 6.6, 12.0 Hz, 5-H of pyrazoline), 7.04 (d,
1H, J = 8.9 Hz, ArAH), 7.18 (d, 1H, J = 2.7 Hz, ArAH), 7.31–7.48 (m,
9H, ArAH), 7.80–7.82 (m, 2H, ArAH), 9.89 (s, 1H, OH); HRMS: calcd
for [M+H]+ C23H17ClN4OS: 433.0890; found: 433.0913.
4-Chloro-2-(1-(5-(4-methoxyphenyl)-1,3,4-thiadiazol-2-yl)-5-
phenyl-4,5-dihydro-1H-pyrazol-3-yl)phenol (3b). Yellow solid, yield
80.3%; mp 241–243 °C; IR (KBr, cmꢁ1): 3242.2, 3058.2, 3028.7,
2931.3, 1607.7, 1574.9, 1524.7, 1458.9; 1H NMR (300 MHz, CDCl3):
d 3.46 (dd, 1H, J = 6.3, 17.7 Hz, 4-Htrans), 3.84 (s, 3H, CH3), 4.07 (dd,
1H, J = 12.0, 17.7 Hz, 4-Hcis), 5.76 (dd, 1H, J = 6.3, 12.0 Hz, 5-H of
pyrazoline), 6.92 (d, 2H, J = 9.6 Hz, ArAH), 7.02 (d, 1H, J = 9.0 Hz,
ArAH), 7.16 (d, 1H, J = 2.4 Hz, ArAH), 7.27–7.40 (m, 6H, ArAH),
7.73 (d, 2H, J = 8.7 Hz, ArAH), 9.87 (s, 1H, OH); HRMS: calcd for
[M+H]+ C24H19ClN4O2S: 463.0995; found: 463.0993.
4-Chloro-2-(1-(5-(4-chlorophenyl)-1,3,4-thiadiazol-2-yl)-5-phe-
nyl-4,5-dihydro-1H-pyrazol-3-yl)phenol (3c). Yellow solid, yield
43.3%; mp 267–268 °C; IR (KBr, cmꢁ1): 3435.2, 3199.3, 3057.6,
3023.2, 2922.3, 1615.1, 1588.1, 1519.9, 1483.4; 1H NMR
(300 MHz, CDCl3): d 3.48 (dd, 1H, J = 6.0, 18.0 Hz, 4-Htrans), 4.11
(dd, 1H, J = 12.0, 18.0 Hz, 4-Hcis), 5.82 (dd, 1H, J = 6.0, 12.0 Hz, 5-
H of pyrazoline), 7.01 (d, 1H, J = 9.0 Hz, ArAH), 7.16 (d, 1H,
J = 2.4 Hz, ArAH), 7.27–7.39 (m, 8H, ArAH), 7.70 (d, 2H, J = 8.1 Hz,
ArAH), 9.78 (s, 1H, OH); HRMS: calcd for [M+H]+ C23H16Cl2N4OS:
467.0500; found: 467.0512.
graphite monochromated Mo
Ka radiation (k = 0.71073 Å) at
298 K. The structures were solved by direct methods with SHEL-
XS-97 program and refinements on F2 were performed with SHEL-
XL-97 program by full-matrix least-squares techniques with
anisotropic thermal parameters for the non-hydrogen atoms. All
H atoms were initially located in a difference Fourier map. The
methyl H atoms were then constrained to an ideal geometry, with
CAH = 0.96 Å and Uiso(H) = 1.5 Ueq(C). All other H atoms were
placed in geometrically idealized positions and constrained to ride
on their parent atoms, with CAH = 0.93 Å and Uiso(H) = 1.2 Ueq(C).
Results and discussion
Synthesis of compounds 3
The synthetic routes of the proposed compounds 3 are outlined
in Scheme 1. The chalcone derivatives (1) and 5-aryl-2-hydrazinyl-
1,3,4-thiadiazole (2) were prepared according to the literature
[43,44]. The 3,5-diarylpyrazoline derivatives 3a–f were obtained
by the reaction of chalcone 1 with 5-aryl-2-hydrazinyl-1,3,4-thia-
diazole 2 under reflux condition in 43.3–84.7% yields. The struc-
tures of compounds (3a–f) were confirmed by IR, 1H NMR and
HRMS spectral data. The IR spectra of all the compounds 3a–f
showed v
(C@N) stretch at 1587–1607 cmꢁ1 consisting with pyraz-
oline and thiadiazole moiety. In the 1H NMR spectra of compounds
that is shown in Fig. 1, the CH2 protons of the pyrazoline ring res-
onated as a pair of doublets at d 3.46–3.52 ppm (HA), 4.05–